Treatment of Oral Candida Mucositis Infections
Infections due to Candida spp. are increasing in incidence as the number of immune compromised patients increases. The common presentation of Candida mucositis and oral infections includes atrophic candidiasis, angular cheilitis, leukoplakia and oesophagitis. An increasing spectrum of antifungal agents, including imidazoles, are available for treatment and suppression of this common infection. In chronically immune-compromised patients such as those with severe HIV related immune deficiency, eradication of the infection may not be possible. This requires a stepwise approach to management and may require the use of potent, toxic agents such as amphotericin B to suppress the symptoms and signs of infection sufficiently to provide the patient with symptomatic relief. Resistant organisms are also becoming a greater problem in this patient population.
KeywordsFluconazole Candidiasis Ketoconazole Antifungal Therapy Nystatin
Unable to display preview. Download preview PDF.
- Crislip MA, Edwards Jr JE. Candida albicans and related species. In Gorbach et al. (Eds) Infectious diseases, pp. 1887–1889, WB Saunders Co., Philadelphia, 1992Google Scholar
- Edwards Jr JE. Candida species. In Mandell et al. (Eds) Principles and practice of infectious disease, pp. 1943–1949, Churchill Livingstone Inc., New York, 1990Google Scholar
- Laine L, Conteus C, Islam MZ, et al. Prospective randomised double blind trial of fluconazole vs ketoconazole for Candida esophagitis. Gastroenterology 100: A591, 1990Google Scholar
- McCloskey R, Hathorn J, Buell DN. Fluconazole vs. clotrimazole treatment of oropharyngeal candidiasis in adults with malignancy. Proceedings of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting, October 21-24,1990, Atlanta, Georgia, Abstract #1280,1990 Americal Society for Microbiology, Washington, DC, 1990Google Scholar